Intratumoral Bacterial Burden Drives Immunotherapy Resistance in Head and Neck Cancer

oncodaily - Immune checkpoint blockade (ICB) benefits only a subset of patients with head and neck squamous cell carcinoma (HNSCC), and commonly used biomarkers (PD-L1, TMB) remain imperfect in this setting. This […]

AI Summary: Researchers reveal that an increased bacterial burden within head and neck tumors may undermine the efficacy of immune checkpoint blockade treatments. Detailed investigations indicate that intratumoral bacteria could be a pivotal factor in treatment resistance, opening new avenues for overcoming these challenges in managing advanced head and neck cancers.

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment

Nivolumab Added to Cisplatin and Radiotherapy Improves DFS in Patients with High-Risk Resected Locally Advanced SCCHN

4 months / esmo

NIVOPOST-OP Trial: Postoperative Nivolumab Plus Cisplatin-Based Chemoradiotherapy in High-Risk Locally Advanced Head and Neck Squamous Cell Carcinoma

4 months / oncodaily

Harnessing the microbiome for cancer therapy

4 months / nature

David Sher: 2 Nature Cancer Papers on Tumor Bacterial Burden and Immunotherapy Response

4 months / oncodaily

Global Incidence of Lip, Oral Cavity, and Pharyngeal Cancers – American Cancer Society Journals

4 months / oncodaily

Intratumoral Bacterial Burden Drives Immunotherapy Resistance in Head and Neck Cancer

4 months / oncodaily

Tumor bacteria linked to immunotherapy resistance in head and neck cancer

4 months / medicalxpress

Judge blocks 340B rebate pilot program

Ella Jeffries / beckershospitalreview - A federal judge granted a temporary restraining order blocking the Department of Health and Human Services from launching its 340B Rebate Model Pilot Program, which was scheduled to begin Jan. 1, 2026. U.S. District Judge Lance Walker of the District of M…

AI Summary: A federal judge has temporarily halted the rollout of a 340B rebate pilot program designed to reshape drug pricing ahead of its January start. The ruling challenges the current administration’s approach to reforming pricing models, casting uncertainty on the initiative’s future.

#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy

HHS may reconsider blocked 340B rebate pilot after court ruling

4 months / beckershospitalreview / Paige Twenter

HHS loses bid to suspend court block on 340B rebate pilot

4 months / endpoints / Alexis Kramer

340B rebate pilot put on hold in temporary win for hospitals

4 months / healthcaredive / Rebecca Pifer

Judge blocks 340B rebate pilot program

5 months / beckershospitalreview / Ella Jeffries

Federal judge blocks 340B drug pricing pilot ahead of Jan. 1 effective date

5 months / endpoints / Nicole DeFeudis

StackHealth RSS

You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Infant Health, Clinical Trials, Cancer Screening, Adolescent Health and look for the RSS link.

StackHealth Time Machine

More StackHealth